Cargando…

The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis

BACKGROUND: By now, the incidence of chronic kidney disease (CKD) is increasing. The development of various CKD is attributed to the continuous aggravation of renal interstitial fibrosis (RIF) in the process of end-stage renal disease (ESRD). Oral treatment of traditional Chinese medicine (TCM) is o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guang, Guo, Mao, Zou, Junju, Zhou, Xiaotao, Ma, Yuerong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505365/
https://www.ncbi.nlm.nih.gov/pubmed/32957343
http://dx.doi.org/10.1097/MD.0000000000022181
_version_ 1783584795598520320
author Yu, Guang
Guo, Mao
Zou, Junju
Zhou, Xiaotao
Ma, Yuerong
author_facet Yu, Guang
Guo, Mao
Zou, Junju
Zhou, Xiaotao
Ma, Yuerong
author_sort Yu, Guang
collection PubMed
description BACKGROUND: By now, the incidence of chronic kidney disease (CKD) is increasing. The development of various CKD is attributed to the continuous aggravation of renal interstitial fibrosis (RIF) in the process of end-stage renal disease (ESRD). Oral treatment of traditional Chinese medicine (TCM) is one of the therapies for RIF. Randomized controlled trials (RCTs) of TCM treatment RIF have been reported, but its effectiveness and safety have yet been systematically investigated. Therefore, through the systematic analysis and meta-analysis, our study will summarize the effectiveness and safety of oral treatment RIF of TCM, in order to provides scientific reference for clinical practice. METHODS: This protocol follows Preferred Reporting Items for Systematic Evaluation and Meta-Analysis. RCTs will be only selected. Such databases as the PubMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Excerpt Medical Database (Embase), WanFan Data, Chinese Biomedical Literature Database (CBM), WHO International Clinical Trials Registry Platform will be searched from the inception to June, 2020 to collect the RCTs about taking TCM orally in treating RIF. The literature according to the inclusion and exclusion criteria, data-extracted and the methodological quality evaluated will be performed independently by 2 reviewers. The clinical outcomes including renal function indices (Scr, BUN, 24-hour urinary protein quantity) and Indicators of RIF (TGF-β1, Notch1, Jagged-1). The risk of bias included in the RCTs will be evaluated by the bias risk assessment tool provided in the Cochrane System Evaluation Manual 5.1.0. Review Manager 5.3 provided by the Cochrane collaboration network will be used to process the data. RESULTS AND CONCLUSION: Some more targeted and practical results about the efficacy of taking TCM orally in RIF have been provided by our study. The available evidence suggests that the therapeutic effects of combining TCM with Western medicine therapies is much better for RIF than Western medicine therapies only.
format Online
Article
Text
id pubmed-7505365
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75053652020-09-24 The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis Yu, Guang Guo, Mao Zou, Junju Zhou, Xiaotao Ma, Yuerong Medicine (Baltimore) 3800 BACKGROUND: By now, the incidence of chronic kidney disease (CKD) is increasing. The development of various CKD is attributed to the continuous aggravation of renal interstitial fibrosis (RIF) in the process of end-stage renal disease (ESRD). Oral treatment of traditional Chinese medicine (TCM) is one of the therapies for RIF. Randomized controlled trials (RCTs) of TCM treatment RIF have been reported, but its effectiveness and safety have yet been systematically investigated. Therefore, through the systematic analysis and meta-analysis, our study will summarize the effectiveness and safety of oral treatment RIF of TCM, in order to provides scientific reference for clinical practice. METHODS: This protocol follows Preferred Reporting Items for Systematic Evaluation and Meta-Analysis. RCTs will be only selected. Such databases as the PubMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Excerpt Medical Database (Embase), WanFan Data, Chinese Biomedical Literature Database (CBM), WHO International Clinical Trials Registry Platform will be searched from the inception to June, 2020 to collect the RCTs about taking TCM orally in treating RIF. The literature according to the inclusion and exclusion criteria, data-extracted and the methodological quality evaluated will be performed independently by 2 reviewers. The clinical outcomes including renal function indices (Scr, BUN, 24-hour urinary protein quantity) and Indicators of RIF (TGF-β1, Notch1, Jagged-1). The risk of bias included in the RCTs will be evaluated by the bias risk assessment tool provided in the Cochrane System Evaluation Manual 5.1.0. Review Manager 5.3 provided by the Cochrane collaboration network will be used to process the data. RESULTS AND CONCLUSION: Some more targeted and practical results about the efficacy of taking TCM orally in RIF have been provided by our study. The available evidence suggests that the therapeutic effects of combining TCM with Western medicine therapies is much better for RIF than Western medicine therapies only. Lippincott Williams & Wilkins 2020-09-18 /pmc/articles/PMC7505365/ /pubmed/32957343 http://dx.doi.org/10.1097/MD.0000000000022181 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 3800
Yu, Guang
Guo, Mao
Zou, Junju
Zhou, Xiaotao
Ma, Yuerong
The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis
title The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis
title_full The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis
title_fullStr The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis
title_full_unstemmed The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis
title_short The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis
title_sort efficacy of taking traditional chinese medicine orally in renal interstitial fibrosis: a protocol for a systematic review and meta-analysis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505365/
https://www.ncbi.nlm.nih.gov/pubmed/32957343
http://dx.doi.org/10.1097/MD.0000000000022181
work_keys_str_mv AT yuguang theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT guomao theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT zoujunju theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT zhouxiaotao theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT mayuerong theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT yuguang efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT guomao efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT zoujunju efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT zhouxiaotao efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis
AT mayuerong efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis